Kangmei Pharma | 600518 - 売上総利益

株価
1.75
毎日の変更
-0.01 -0.57%
毎月
-6.42%
毎年
-13.37%
Q2 予測
1.72




売上総利益 変化する 日付
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Genomma Lab Internacional MXN 2.45B 386.92M 2025-12
Hypermarcas BRL 1.38B 16.08M 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Jiangsu Hengrui CNY 6.36B 1.15B 2025-09
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Moderna USD 226M 583M 2025-12
Organon & Co USD 854M 3M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Sh Fosun Pharma CNY 4.8B 93.72M 2025-09
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.15B 223.6M 2025-12
Wuxi Apptec CNY 6.12B 958.48M 2025-09
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06